RSS-Feed abonnieren
DOI: 10.1055/s-0038-1650283
Tissue Factor Induces Migration of Cultured Aortic Smooth Muscle Cells
Publikationsverlauf
Received: 26. September 1995
Accepted after revision14. Dezember 1995
Publikationsdatum:
26. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199603/lookinside/thumbnails/10-1055-s-0038-1650283-1.jpg)
Summary
Tissue factor (TF) plays a key role as a primary initiator on the extrinsic coagulation cascade. Recently, upregulation of TF has been reported in human atherosclerotic lesions. We investigated the effects of TF on migration and proliferation of cultured smooth muscle cells (SMCs) from rabbit aortas. We tested three kinds of recombinant human TF (L-TF: the full length of TF with relipidation, NL-TF: the full length of TF without relipidation, and S-TF: a soluble form of TF1-219). Only L-TF had coagulant activity. All kinds of TF showed the chemotactic migration activity for SMCs. The migration ability of TFs was comparable to those of platelet-derived growth factor (PDGF)-BB and basic fibroblast-growth factor (bFGF), and was inhibited by anti-TF polyclonal and monoclonal antibodies. On the other hand, none of the forms of TF induced SMC proliferation. These results indicate that TF is not only a coagulation factor but also a strong chemotactic factor for vascular SMCs, and suggest that TF could play an important role in atherogenesis as well as in hemostasis and thrombosis.
-
References
- 1 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
- 2 Schwartz SM, Liaw L. Growth control and morphogenesis in the development and pathology of arteries. J Cardiovasc Pharmacol 1993; 21: 521-549
- 3 Naito M, Hayashi T, Kuzuya M, Funaki C, Asai K, Kuzuya F. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis 1990; 83: 9-14
- 4 McNamara CA, Sarembock IJ, Gimple LW, Fenton II JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-98
- 5 Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 1992; 89: 2317-2320
- 6 Wada H, Nakase T, Nakaya R, Minamikawa K, Wakita Y, Taneko T, Ohiwa M, Deguchi K, Shirakawa S. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hema-tol 1994; 45: 232-236
- 7 Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, Kuriyama R, Matsuzawa K, Hasegawa R, Aoki N. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994; 87: 343-347
- 8 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843
- 9 Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253-2259
- 10 Annex BH, Denning SM, Channon KM, Sketch Jr MH, Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-622
- 11 Ishii H, Horie S, Kizaki K, Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 1992; 80: 2556-2562
- 12 Imamura T, Iyama K, Takeya M, Kambara T, Nakamura S. Role of macrophage tissue factor in development of the delayed hypersensitivity reaction in monkey skin. Cell Immunol 1993; 152: 614-622
- 13 Grotendorst GR, Chang T, Seppa HEJ, Kleinman HK, Martin GR. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol 1982; 113: 261-266
- 14 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134: 1087-1097
- 15 Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal antihuman tissue factor antibody. Thromb Res 1990; 57: 765-781
- 16 Pettersen KS, Wiiger MT, Narahara N, Andoh K, Gaudemack G, Prydz H. Induction of tissue factor synthesis in human umbilical vein endothelial cells involves protein kinase C. Thromb Haemost 1992; 67: 473-477
- 17 Taubman MB, Marmur JD, Rosenfield C-L, Guha A, Nichtberger S, Nemerson Y. Agonist-mediated tissue factor expression in cultured smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest 1993 91. 547-552
- 18 Ryan J, Brett J, Tijburg P, Bach RR, Kisiel W, Stem D. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood 1992; 80: 966-974
- 19 Bona R, Lee E, Rickies F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res 1987; 48: 487-500
- 20 Tipping PG, Campbell DA, Boyce NW, Holdsworth SR. Alveolar macrophage procoagulant activity is increased in acute hyperoxic lung injury. Am J Pathol 1988; 131: 206-212
- 21 Broze Jr GJ. Tissue factor pathway inhibitor. Thromb Haemost 1995; 74: 90-93
- 22 Rpttingen J-A, Enden T, Camerer E, Iversen J-G, Prydz H. Binding of human factor Vila to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 1995; 270: 4650-4660